Skip to main content
Caplight Logo









PatenSee

PatenSee

Private
Or YehudaHealthcare & Life Scienceshttps://patensee.com/

Last Round

Seed

Feb 20, 2025

Total Funding Raised

$2.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PatenSee is a medical devices company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients using advanced, multi-modal imaging technologies and AI.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

hemodialysis monitoringvascular access monitoringmedical deviceclinical decision supportend-stage renal diseaseESRDAI-powered diagnosticsremote patient monitoringRPMcomputer visionnon-invasive monitoringdigital healthmedtechhealth IoTdialysis care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PatenSee Comparables

Compare PatenSee with similar companies based on industry and business-model similarity.

PatenSee comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NephTech Pte Ltd
87%
Vexev
84%
Auvi Labs
83%

PatenSee Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 20, 2025
Series AFeb 24, 2022
SeedMay 18, 2021

Key People

Founding team and executive leadership

Paul Neeb

President, CEO And Director

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 455% MoM, from 199 to 1.1K.

  • Jan 1, 2026

    Paul Neeb, a seasoned early-stage CEO, will take over as CEO on January 1, 2026.

PatenSee Filings

Explore SEC and related filing metadata, where available.

PatenSee filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PatenSee's valuation, stock price, and market status.

Is PatenSee a public or private company?

PatenSee is a private company.

What is the current stock price of PatenSee?

PatenSee is a private company with no public stock price. No recent secondary market data is available.

How much is PatenSee worth (valuation)?

Valuation information for PatenSee is not publicly available.

Can I buy PatenSee stock?

PatenSee shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PatenSee's last funding round?

PatenSee's most recent funding round was Seed on February 20, 2025.

Who are the main investors in PatenSee?

Key investors in PatenSee include Michigan Rise.

Will PatenSee IPO soon?

No public IPO plans have been announced for PatenSee.

How can I track PatenSee secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PatenSee's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOr Yehuda
Employee Range10
Year Founded2019
Last FundingFeb 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?